Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 422

1.

Fibromyalgia and Physical Trauma: The Concepts We Invent.

Wolfe F, Häuser W, Walitt BT, Katz RS, Rasker JJ, Russell AS.

J Rheumatol. 2014 Aug 1. pii: jrheum.140268. [Epub ahead of print]

PMID:
25086080
[PubMed - as supplied by publisher]
2.

Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study.

Westhovens R, Kremer JM, Emery P, Russell AS, Alten R, Barré E, Dougados M.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):553-62. Epub 2014 Jul 8.

PMID:
25005467
[PubMed - in process]
3.

Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients.

Ferrari R, Russell AS.

Clin Rheumatol. 2014 Jul 3. [Epub ahead of print]

PMID:
24985043
[PubMed - as supplied by publisher]
4.

The challenge of indication extrapolation for infliximab biosimilars.

Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC, Russell AS.

Biologicals. 2014 Jul;42(4):177-83. doi: 10.1016/j.biologicals.2014.05.005. Epub 2014 Jun 21. Review.

PMID:
24962198
[PubMed - in process]
Free Article
5.

Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.

Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH.

Osteoporos Int. 2014 Sep;25(9):2173-9. doi: 10.1007/s00198-014-2728-z. Epub 2014 May 7.

PMID:
24803330
[PubMed - in process]
6.

Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.

Kremer JM, Peterfy C, Russell AS, Emery P, Abud-Mendoza C, Sibilia J, Becker JC, Westhovens R, Genant HK.

J Rheumatol. 2014 Jun;41(6):1077-87. doi: 10.3899/jrheum.130263. Epub 2014 May 1.

PMID:
24786925
[PubMed - in process]
Free Article
7.

Perceived injustice in fibromyalgia and rheumatoid arthritis.

Ferrari R, Russell AS.

Clin Rheumatol. 2014 Mar 4. [Epub ahead of print]

PMID:
24584485
[PubMed - as supplied by publisher]
8.

Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.

Ohinmaa AE, Thanh NX, Barnabe C, Martin L, Russell AS, Barr SG, Maksymowych WP.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1319-27. doi: 10.1002/acr.22293.

PMID:
24470178
[PubMed - in process]
9.

Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countries.

Prankerd RJ, Nguyen TH, Ibrahim JP, Bischof RJ, Nassta GC, Olerile LD, Russell AS, Meiser F, Parkington HC, Coleman HA, Morton DA, McIntosh MP.

PLoS One. 2013 Dec 23;8(12):e82965. doi: 10.1371/journal.pone.0082965. eCollection 2013.

PMID:
24376618
[PubMed - in process]
Free PMC Article
10.

The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labels.

Castillo-Ortiz JD, Russell AS, Davis P, Vargas-Serafin CO, Ramirez-Gomez A, Aceves-Avila FJ, De la Mora-Molina H, Gonzalez-Leija ME, Pacheco-Lorenzo R, Ramos-Remus C.

Clin Rheumatol. 2014 Apr;33(4):561-6. doi: 10.1007/s10067-013-2407-z. Epub 2013 Oct 10.

PMID:
24114394
[PubMed - in process]
11.

A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice.

Ferrari R, Russell AS.

J Rheumatol. 2013 Sep;40(9):1590-5. doi: 10.3899/jrheum.130367. Epub 2013 Jul 1.

PMID:
23818707
[PubMed - indexed for MEDLINE]
12.

QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy.

Russell AS, Lisboa L, Santos MF, Kumar D, Humar A.

Clin Rheumatol. 2013 Nov;32(11):1657-9. doi: 10.1007/s10067-013-2298-z. Epub 2013 Jun 11. No abstract available.

PMID:
23754242
[PubMed - indexed for MEDLINE]
13.

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience.

Russell AS, Mallon C, Conner-Spady B, Maksymowych W.

Clin Rheumatol. 2013 Jun;32(6):875-7. doi: 10.1007/s10067-013-2177-7. Epub 2013 Feb 2.

PMID:
23377198
[PubMed - indexed for MEDLINE]
14.

Cost-effectiveness of osteoporosis interventions for 'incidental' vertebral fractures.

Majumdar SR, Lier DA, McAlister FA, Rowe BH, Siminoski K, Hanley DA, Russell AS, Johnson JA.

Am J Med. 2013 Feb;126(2):169.e9-17. doi: 10.1016/j.amjmed.2012.10.009.

PMID:
23331449
[PubMed - indexed for MEDLINE]
15.

Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.

Maksymowych WP, Russell AS, Chiu P, Yan A, Jones N, Clare T, Lambert RG.

Arthritis Res Ther. 2012 Oct 4;14(5):R206. doi: 10.1186/ar4044.

PMID:
23036475
[PubMed - in process]
Free PMC Article
16.

Palindromic rheumatism: a pre-rheumatoid arthritis state?

Katz SJ, Russell AS.

J Rheumatol. 2012 Oct;39(10):1912-3. doi: 10.3899/jrheum.120995. No abstract available.

PMID:
23028026
[PubMed - indexed for MEDLINE]
17.

Interventions to increase osteoporosis treatment in patients with 'incidentally' detected vertebral fractures.

Majumdar SR, McAlister FA, Johnson JA, Bellerose D, Siminoski K, Hanley DA, Qazi I, Lier DA, Lambert RG, Russell AS, Rowe BH.

Am J Med. 2012 Sep;125(9):929-36. doi: 10.1016/j.amjmed.2012.02.021.

PMID:
22938928
[PubMed - indexed for MEDLINE]
18.

Subsequent entry biologics/biosimilars: a viewpoint from Canada.

Russell AS, Ahluwalla V, Barnabe C, Jamal S, Offer RC, Olszynski WP, Shojania K, Haraoui B.

Clin Rheumatol. 2012 Sep;31(9):1289-92. doi: 10.1007/s10067-012-2066-5. Epub 2012 Aug 26. Review.

PMID:
22923182
[PubMed - indexed for MEDLINE]
19.

Whiplash: nothing to lose sleep over.

Ferrari R, Russell AS.

J Rheumatol. 2012 Mar;39(3):655; author reply 656-7. doi: 10.3899/jrheum.110970. No abstract available.

PMID:
22383355
[PubMed - indexed for MEDLINE]
20.

Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.

Nanji JA, Choi M, Ferrari R, Lyddell C, Russell AS.

J Rheumatol. 2012 Apr;39(4):707-11. doi: 10.3899/jrheum.110818. Epub 2012 Feb 15.

PMID:
22337235
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk